SNCA and Parkinson disease: This increased PARK1 activity leads to increased expression of mutant α-synuclein and therefore an increase in cytoplasmic dopamine as described in the case of autosomal dominant PD (Vila et al., 2000) and provides crucial insight into the study of PD.